Skip to main content

Advertisement

Log in

Repairing defect and preventing collapse of femoral head in a steroid-induced osteonecrotic of femoral head animal model using strontium-doped calcium polyphosphate combined BM-MNCs

  • Biocompatibility Studies
  • Published:
Journal of Materials Science: Materials in Medicine Aims and scope Submit manuscript

Abstract

We investigated the synergism between strontium-doped calcium polyphosphate (SCPP) and autologous bone marrow mononuclear cells (BM-MNCs) in treating osteonecrosis of the femoral head (ONFH). ONFH was confirmed histopathologically at 2 weeks after methylprednisolone acetate injection and the rabbits were treated with morselized autogenous cancellous compacted bone graft (group I), SCPP combined with BM-MNCs (group II), and calcium polyphosphate (group III), respectively. The amount of newly formed bone in group II increased dramatically by 4, 8, and 12 weeks and much more than that in group III (P < 0.05). VEGF expression in group I was significantly higher than in group II (P = 0.023), and its expression in group II was significantly higher than in group III (P = 0.017). At 12 weeks, group II had articular cartilage collapse and group III had joint-space narrowing. The mean histological and radiological scores for repaired defects in group II were significantly higher than those in group III (P = 0.000) but lower than those in group I (P = 0.000). The implantation of a combination of SCPP and BM-MNCs enhances VEGF expression and promotes osteogenesis, which may improve angiogenesis and allow incorporation and remodeling into new trabecular bone without mechanical weakening.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Marker DR, Seyler TM, McGrath MS, Delanois R, Ulrich SD, Mont MA. Treatment of early stage osteonecrosis of the femoral head. J Bone Joint Surg Am. 2008;90(suppl4):175–87.

    Article  Google Scholar 

  2. McGrory BJ, York SC, Iorio R, Macaulay W, Pelker RR, et al. Current practices of AAHKS members in the treatment of adult osteonecrosis of the femoral head. J Bone Joint Surg Am. 2007;89:1194–204.

    Article  Google Scholar 

  3. Lieberman JR, Berry DJ, Mont MA, Aaron RK, Callaghan JJ, Rajadhyaksha AD, Urbaniak JR. Osteonecrosis of the hip: management in the 21st century. Instr Course Lect. 2003;52:337–55.

    Google Scholar 

  4. Mont MA, Zywiel MG, Marker DR, McGrath MS, Delanois RE. The natural history of untreated asymptomatic osteonecrosis of the femoral head: A systematic literature review. J Bone Joint Surg Am. 2010;92:2165–70.

    Article  Google Scholar 

  5. Mont MA, Jones LC, Hungerford DS. Nontraumatic osteonecrosis of the femoral head: ten years later. Bone Joint Surg Am. 2006;88:1117–32.

    Article  Google Scholar 

  6. Kang P, Shen B, Yang J, Cheng J, Pei F. Repairing defect and preventing collapse of canine femoral head using titanium implant enhanced by autogenous bone graft and rhBMP-2. Connect Tissue Res. 2007;48:171–9.

    Article  Google Scholar 

  7. Cui Q, Botchwey EA. Emerging ideas: treatment of precollapse osteonecrosis using stem cells and growth factors. Clin Orthop Relat Res. 2011;469:2665–9.

    Article  Google Scholar 

  8. Tang TT, Lu B, Yue B, Xie XH, Xie YZ, Dai KR, et al. Treatment of osteonecrosis of the femoral head with hBMP-2-gene-modified tissue-engineered bone in goats. J Bone Joint Surg Br. 2007;89:127–9.

    Article  Google Scholar 

  9. Marciniak D, Furey C, Shaffer JW. Mechanical consequences of core drilling and bone-grafting on osteonecrosis of the femoral head. J Bone Joint Surg Am. 1993;75:1358–67.

    Google Scholar 

  10. Chen CC, Lin CL, Chen WC, Shih HN, Ueng SWN, Lee MS. Vascularized iliac bone-grafting for osteonecrosis with segmental collapse of the femoral head. J Bone Joint Surg Am. 2009;91:2390–4.

    Article  Google Scholar 

  11. Gu Z, Zhang X, Li L, Wang Q, Yu X, Feng T. Acceleration of segmental bone regeneration in a rabbit model by strontium-doped calcium polyphosphate scaffold through stimulating VEGF and bFGF secretion from osteoblasts. Mater Sci Eng, C. 2013;33:274–81.

    Article  Google Scholar 

  12. Li Y, Li J, Zhu S, Luo E, Feng G, Chen Q, et al. Effects of strontium on proliferation and differentiation of rat bone marrow mesenchymal stem cells. Biochem Biophys Res Commun. 2012;418:725–30.

    Article  Google Scholar 

  13. Che YW, Feng T, Shi GQ, Ding YL, Yu XX, Zhang XH, et al. Interaction of endothelial cells with biodegradable strontium-doped calcium polyphosphate for bone tissue engineering. Appl Surf Sci. 2008;255:331–5.

    Article  Google Scholar 

  14. Tat SK, Pelletier JP, Mineau F, Caron Jh, Martel-Pelletier J. Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts. Bone. 2011;49:559–67.

    Article  Google Scholar 

  15. Li Z, Lu WW, Chiu PKY, Lam RWM, Xu B, Chung KMC, et al. Strontium-calcium coadministration stimulates bone matrix osteogenic factor expression and new bone formation in a large animal model. J Orthop Res. 2009;27:758–62.

    Article  Google Scholar 

  16. Barbara A, Delannoy P, Denis BG, Marie PJ. Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells. Metabolism. 2004;53:532–7.

    Article  Google Scholar 

  17. Choudhary S, Halbout P, Alander C, Raisz L, Pilbeam C. Strontium ranelate promotes osteoblastic differentiation and mineralization of murine bone marrow stromal cells: involvement of prostaglandins. J Bone Miner Res. 2007;22:1002–10.

    Article  Google Scholar 

  18. Takahashi N, Sasaki T, Tsouderos Y, Suda T. S 12911-2 inhibits osteoclastic bone resorption in vitro. J Bone Miner Res. 2003;18:1082–7.

    Article  Google Scholar 

  19. Baron R, Tsouders Y. In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation. Eur J Pharmacol. 2002;450:11–7.

    Article  Google Scholar 

  20. Henrotin Y, Labasse A, Zheng SX, Galais P, Tsouderos Y, Crielaard JM, et al. Strontium ranelate increases cartilage matrix formation. J Bone Miner Res. 2001;16:299–308.

    Article  Google Scholar 

  21. Bonnelye E, Chabadel A, Saltel F, Jurdic P. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of formation and resorption in vitro. Bone. 2008;42:129–38.

    Article  Google Scholar 

  22. Gu Z, Xie H, Li L, Zhang X, Liu F, Yu X. Application of strontium-doped calcium polyphosphate scaffold on angiogenesis for bone tissue engineering. J Mater Sci Mater Med. 2013;24(5):1251–60.

    Article  Google Scholar 

  23. Chen YW, Shi GQ, Ding YL, Yu XX, Zhang XH, Zhao CS, Wan CX. In vitro study on the influence of strontium-doped calcium polyphosphate on the angiogenesis-related behaviors of HUVECS. J Mater Sci Mater Med. 2008;19:2655–62.

    Article  Google Scholar 

  24. Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res. 2002;405:14–23.

    Article  Google Scholar 

  25. Gangji V, Maertelaer VD, Hauzeur JP. Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: five year follow-up of a prospective controlled study. Bone. 2011;49:1005–9.

    Article  Google Scholar 

  26. Zhao D, Cui D, Wang B, Tian F, Guo L, Yang L, et al. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells. Bone. 2012;50:325–30.

    Article  Google Scholar 

  27. Gangji V, Hauzeur JP. Treating osteonecrosis with autologous bone marrow cells. Skeletal Radiol. 2010;39:209–11.

    Article  Google Scholar 

  28. Qiu K, Zhao XJ, Wan CX, Zhao CS, Chen YW. Effect of strontium ions on the growth of ROS17/2.8 cells on porous calcium polyphosphate scaffolds. Biomaterials. 2006;27:1277–86.

    Article  Google Scholar 

  29. Miyanishi K, Yamamoto T, Irisa T, Yamashita A, Jingushi S, Noguchi Y, et al. Bone marrow fat cell enlargement and a rise in intraosseous pressure in steroid-treated rabbits with osteonecrosis. Bone. 2002;30:185–90.

    Article  Google Scholar 

  30. Kang PD, Pei FX, Shen B, Yang J, Zhou ZK, Cheng JQ. Lovastatin inhibits adipogenesis and prevents osteonecrosis in steroid-treated rabbits. Joint Bone Spine. 2008;75:696–701.

    Article  Google Scholar 

  31. Kang P, Gao H, Pei F, Shen B, Yang J, Zhou Z. Effects of an anticoagulant and a lipid-lowering agent on the prevention of steroid-induced osteonecrosis in rabbits. Int J Exp Pathol. 2010;91:235–43.

    Article  Google Scholar 

  32. Mont MA, Jones LC, Elias JJ, Inoue N, Yoon TR, Chao EYS, et al. Strut-autografting with and without osteogentic protein-1: a preliminary study of a canine femoral head defect model. J Bone Join Surg Am. 2001;83:1013–22.

    Google Scholar 

  33. Simkin PA, Downey DJ. Hypothesis: retrograde embolization of marrow fat may cause osteonecrosis. J Rheumatol. 1987;14:870–2.

    Google Scholar 

  34. Gangji V, Hauzeur JP, Schoutens A, Hinsenkamp M, Appelboom T, Egrise D. Abnormalities in the replicative capacity of osteoblastic cells in the proximal femur of patients with osteonecrosis of the femoral head. J Rheumatol. 2003;30:348–51.

    Google Scholar 

  35. Hernigou P, Beaujean F. Abnormalities in the bone marrow of the iliac crest in patients who have osteonecrosis secondary to corticosteroid therapy or alcohol abuse. J Bone Joint Surg Am. 1997;79:1047–53.

    Article  Google Scholar 

  36. Calder JD, Pearse MF, Revell PA. The extent of osteocyte death in the proximal femur of patients with osteonecrosis of the femoral head. J Bone Joint Surg Br. 2001;83:419–22.

    Article  Google Scholar 

  37. Ko JY, Wang FS, Wang CJ, Wong T, Chou WY, Tseng SL. Increased Dickkopf-1 expression accelerates bone cell apoptosis in femoral head osteonecrosis. Bone. 2010;46:584–91.

    Article  Google Scholar 

  38. Gangji V, Hauzeur JP, Matos C, De MV, Toungouz M, Lambermont M. Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J Bone Joint Surg Am. 2004;86:1153–60.

    Google Scholar 

  39. Zhang WB, Shen YH, Pan HB, Lin KL, Liu XG, Darvell BW, et al. Effects of strontium in modified biomaterials. Acta Biomater. 2011;7:800–8.

    Article  Google Scholar 

  40. Capuccini C, Torricelli P, Sima F, Boanini E, Ristoscu C, Bracci B, et al. Strontium-substituted hydroxyapatite coatings synthesized by pulsed-laser deposition: in vitro osteoblast and osteoclast response. Acta Biomater. 2008;4:1885–93.

    Article  Google Scholar 

  41. Braux J, Velard F, Guillaume C, Bouthors S, Jallot E, Nedelec JM, et al. A new insight into the dissociating effect of strontium on bone resorption and formation. Acta Biomater. 2011;7:2593–603.

    Article  Google Scholar 

  42. Ni GX, Yao ZP, Huang GT, Liu WG, Lu WW. The effect of strontium incorporation in hydroxyapatite on osteoblasts in vitro. J Mater Sci Mater Med. 2011;22:961–7.

    Article  Google Scholar 

  43. Gentleman E, Fredholm YC, Jell G, Lotfibakhshaiesh N, O’Donnell MD, Hill RG, et al. The effects of strontium-substituted bioactive glasses on osteoblasts and osteoclasts in vitro. Biomaterials. 2010;31:3949–56.

    Article  Google Scholar 

  44. Atkins GJ, Welldon KJ, Findlay DM. Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin response. Osteoporos Int. 2009;20:653–64.

    Article  Google Scholar 

  45. Nia GX, Lua WW, Xu B, Chiu KY, Yang C, Lia ZY, et al. Interfacial behaviour of strontium-containing hydroxyapatite cement with cancellous and cortical bone. Biomaterials. 2006;27:5127–33.

    Article  Google Scholar 

  46. Wang Y, Wan C, Deng L, Liu X, Cao X, Gilbert SR, et al. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest. 2007;117:1616–26.

    Article  Google Scholar 

  47. Marie PJ. Strontium renelate: a new insight into its dual model of action. Bone. 2007;40:5–8.

    Article  Google Scholar 

  48. Karsenty G. The complexities of skeletal biology. Nature. 2003;423:316–8.

    Article  Google Scholar 

  49. Zhu LL, Zaidi S, Peng Y, Zhou H, Moonga BS, Blesius A, et al. Induction of a program gene expression during osteoblast differentiation with strontium ranelate. Biochem Biophy Res Commun. 2007;355:307–11.

    Article  Google Scholar 

Download references

Acknowledgments

This research was funded by the National Natural Science Fund of China (Grants 81271976/H0605, 81171763, and 30772202/C1607) and the Sichuan Province Science and Technology Support Program (Grant 2011SZ0027).

Conflict of interest

We declare that we have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pengde Kang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kang, P., Xie, X., Tan, Z. et al. Repairing defect and preventing collapse of femoral head in a steroid-induced osteonecrotic of femoral head animal model using strontium-doped calcium polyphosphate combined BM-MNCs. J Mater Sci: Mater Med 26, 80 (2015). https://doi.org/10.1007/s10856-015-5402-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10856-015-5402-x

Keywords

Navigation